China SFDA Warns Public Against Overuse Of Antibiotics
This article was originally published in PharmAsia News
China's State FDA warned the public against overuse of antibiotics, citing potential side effects and the danger of diseases developing resistance to the drugs.
You may also be interested in...
China insists there is no double standard and won’t tolerate any quality issues in its centralized procurement process.
Butterfly Network is disseminating the lessons from China and Italy about the poential value of lung ultrasound in the management of COVID-19 patients with respiratory disease.
Japan approval for BTK inhibitor marks new indication but in a small niche market, while another clearance may help extend Latuda's commercial life.